Âé¶¹´«Ã½

Sectors
A woman with straight brown hair, wearing a navy blazer and light shirt, smiles at the camera. The softly blurred background hints at a corporate law office in Chicago, creating a professional atmosphere.

Sarah R. Field

Senior Counsel

Sarah Field is a senior counsel with Âé¶¹´«Ã½ and a member of the firm’s Transactions Practice Group. She advises clients across a range of corporate matters, with a practice focused on mergers and acquisitions, venture financings, corporate governance, joint ventures, and commercial contracting.

Sarah regularly represents founders, investors, and operating companies in strategic transactions throughout the business lifecycle. Her experience includes advising emerging companies and established businesses on acquisitions and divestitures, equity financings, governance matters, and complex commercial arrangements. She also serves as a trusted counselor to clients on day-to-day corporate matters and other strategic initiatives.

Before joining Âé¶¹´«Ã½, Sarah served as a summer associate with the firm. She also interned with the Federal Trade Commission, Bureau of Competition, Health Division, and with the U.S. District Court for the District of Columbia in the chambers of Judge Richard J. Leon. Earlier in her career, Sarah worked for a member of the United States Senate as a legislative correspondent covering healthcare policy and as an assistant to the chairman of the Democratic Senatorial Campaign Committee. She played Division I varsity field hockey at Princeton University.

May 8, 2026 Deals and Wins

Âé¶¹´«Ã½ Advises Crown Affair in Series C Investment Led by Stride Consumer Partners

Âé¶¹´«Ã½ served as legal advisor to Crown Affair—an emerging luxury haircare brand recognized for its clean, high-performing formulas and emphasis on thoughtful haircare rituals—in its Series C investment led by private equity firm Stride Consumer Partners. 
April 20, 2026 Deals and Wins

Âé¶¹´«Ã½ Advises EpiVax in Acquisition by SV Health Investors

Âé¶¹´«Ã½ served as legal advisor to EpiVax Inc., a leading bioanalytical contract research organization specializing in immunogenicity risk assessments for pharmaceutical and biotech companies, in its acquisition by SV Health Investors, a health care and life sciences focused private investment firm.
October 10, 2025 Deals and Wins

Âé¶¹´«Ã½ Advises TruStageâ„¢ in Sale of Digital Storefront Business

Âé¶¹´«Ã½ served as legal advisor to TruStage, a financially strong insurance and financial services provider founded in 1935, in the sale of its Digital Storefront business to Demopolis Equity Partners.
August 2, 2024 Deals and Wins

Âé¶¹´«Ã½ Advises Hanger Ventures on Inaugural Investment in Bionic Power

Âé¶¹´«Ã½ represented Hanger Ventures, a subsidiary of Hanger, Inc. focused on advancing orthotics and prosthetics innovation and improving patient outcomes, in its inaugural investment in Bionic Power
July 22, 2022 Deals and Wins

Âé¶¹´«Ã½ Represents Hanger in Acquisition by Patient Square Capital

Âé¶¹´«Ã½ represented Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, in its definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm.
October 29, 2020 Press Releases

Âé¶¹´«Ã½ Represents Magellan Health in Kaden Health Investment

Âé¶¹´«Ã½ & Lardner represented Magellan Health (NASDAG:MGLN) in a strategic equity investment in digital behavioral health company Kaden Health, Inc. Magellan’s investment will help Kaden scale access to its proprietary services and platform in behavioral health services.